The global anti-infective drugs market is projected to experience substantial growth, reaching US$ 177.9 billion by 2031, driven by factors such as the increasing prevalence of infectious diseases, rising awareness of hygiene and prevention, advancements in drug development, and the growing threat of antimicrobial resistance.